The early response of renal cell carcinoma to tyrosine kinase inhibitors evaluated by FDG PET/CT was not influenced by metastatic organ

被引：0
|
作者：
Manabu Kakizoe
Masahiro Yao
Ukihide Tateishi
Ryogo Minamimoto
Daiki Ueno
Kazuhiro Namura
Kazuhide Makiyama
Narihiko Hayashi
Futoshi Sano
Takeshi Kishida
Kazuki Kobayashi
Sumio Noguchi
Ichiro Ikeda
Yoshiharu Ohgo
Masataka Taguri
Satoshi Morita
Tomio Inoue
Yoshinobu Kubota
Noboru Nakaigawa
机构：
[1] Yokohama City University Graduate School of Medicine,Department of Urology
[2] Yokohama City University Graduate School of Medicine,Department of Radiology
[3] Kanagawa Cancer Center,Department of Urology
[4] Yokosuka Kyosai Hospital,Department of Urology
[5] Yokohama Minami Kyosai Hospital,Department of Urology
[6] Yokohama Sakae Kyosai Hospital,Department of Urology
[7] Yokohama City University Graduate School of Medicine,Department of Biostatistics and Epidemiology
[8] Kyoto University Graduate School of Medicine,Department of Biomedical Statistics and Bioinformatics
来源：
BMC Cancer | / 14卷
关键词：
Renal cell carcinoma; Tyrosine kinase inhibitor; FDG PET/CT; Metastasis; Standardized uptake value; SUVmax; Organ;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Extensive Metastatic Sarcomatoid Renal Cell Carcinoma Evaluated by F-18-FDG PET/CT: a Case Report and Review of Literature
    Fuser, Dominique
    Hedberg, Matthew L.
    Dehner, Louis P.
    Dehdashti, Farrokh
    Siegel, Barry A.
    JOURNAL OF KIDNEY CANCER AND VHL, 2018, 5 (01): : 1 - 6
  • [32] Novel tyrosine kinase inhibitors for renal cell carcinoma
    Dorff, Tanya B.
    Pal, Sumanta K.
    Quinn, David I.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (01) : 67 - 73
  • [33] SUVmax evaluated by FDG-PET/CT predict survival for patients with advanced renal cell carcinoma
    Nakaigawa, N.
    Yao, M.
    Tateishi, U.
    Kobayashi, K.
    Kishida, T.
    Kondoh, K.
    Makiyama, K.
    Inoue, T.
    Kubota, Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S655
  • [34] Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?
    Calvani, Nicola
    Morelli, Franco
    Chiuri, Vincenzo
    Gnoni, Antonio
    Scavelli, Claudio
    Fedele, Palma
    Orlando, Laura
    Maiello, Evaristo
    Lorusso, Vito
    Cinieri, Saverio
    MEDICAL ONCOLOGY, 2013, 30 (02)
  • [35] Prolonged exposure to tyrosine kinase inhibitors or early use of everolimus in metastatic renal cell carcinoma: are the two options alike?
    Nicola Calvani
    Franco Morelli
    Vincenzo Chiuri
    Antonio Gnoni
    Claudio Scavelli
    Palma Fedele
    Laura Orlando
    Evaristo Maiello
    Vito Lorusso
    Saverio Cinieri
    Medical Oncology, 2013, 30
  • [36] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
    Viktoria Stühler
    Jens Bedke
    BMC Medicine, 14
  • [37] Hypogonadism in men treated with tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC) as a clinical biomarker of response
    Afshar, Mehran
    Clarke, Helen
    Porfiri, Emilio
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [38] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors - assessment of intra-tumour heterogeneity
    Stuehler, Viktoria
    Bedke, Jens
    BMC MEDICINE, 2016, 14
  • [39] Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by 18F-FDG PET/CT
    Treglia, G.
    Bongiovanni, M.
    Paone, G.
    Ruberto, T.
    Parvex-Leoni, S.
    Giovanella, L.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2015, 34 (02): : 125 - 127
  • [40] Tyrosine-Kinase Inhibitors Therapies with Mainly Anti-Angiogenic Activity in Advanced Renal Cell Carcinoma: Value of PET/CT in Response Evaluation
    Ranieri, Girolamo
    Marech, Ilaria
    Asabella, Artor Niccoli
    Di Palo, Alessandra
    Porcelli, Mariangela
    Lavelli, Valentina
    Rubini, Giuseppe
    Ferrari, Cristina
    Gadaleta, Cosmo Damiano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (09)
12345